mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.008 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.009 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.009 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.01 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.01 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.01 |
mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.01 |